Global Cancer Nanomedicine Market Outlook 2022 Report

“Global Cancer Nanomedicine Market Outlook 2022” Report Highlights:

* Overview and Mechanism of Action of Nanomedicine
* Nanomedicine Engineering: Design and Strategy
* Cancer Nanomedicine as Diagnostic and Therapeutics Tool
* Global Cancer Nanomedicine Market Overview and Dynamics
* Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
* Global Cancer Nanomedicine Clinical Pipeline: 124 Drug
* Marketed Cancer Nanomedicine: 8 Drugs

Download Report Sample Weblink:

https://www.kuickresearch.com/report-global-cancer-nanomedicine-market-outlook-2022.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

Cancer Nanomedicine: An Optimistic Avenue
1.1 Introduction
1.2 Emergence of Nanomedicines

Prerequisite of Nanomedicines
2.1 Conventional Cancer Treating Approaches
2.2 Nanomedicines: Overcoming the Hurdles

Diversification of Nanomedicines
3.1 Classification on Basis of Constituents
3.1.1 Inorganic Nanoparticles
3.1.2 Organic Nanoparticles
3.2 Classification on Basis of Applicability
3.2.1 Nanomedicine as Diagnostic Agents
3.2.2 Nanomedicine as Therapeutic Agents
3.2.3 Nanomedicine as Drug Delivery Agents
3.3 Classification on Basis of Dimensions

Mechanism of Action of Nanomedicine
4.1 Targeting Tumor Cells
4.1.1 Passive Targeting
4.1.2 Active Targeting
4.2 Nanocarrier - Drug Complex
4.2.1 Liposomes
4.2.2 Dendrimers
4.2.3 Micelles
4.2.4 Inorganic Nanocarriers
4.3 Drug Release Systems

Nanomedicine Engineering: Design and Strategy
5.1 Organic Nanoparticles as Nanomedicines
5.1.1 Polymeric Nanoparticle
5.1.2 Lipid Organic Nanoparticles
5.2 Inorganic Nanoparticles as Nanomedicines
5.2.1 Synthesis of Gold Nanoparticle

Cancer Nanomedicine as Diagnostic Tool
6.1 Detection of Cancer Biomarkers
6.1.1 Detection of Circulating Tumor Cell
6.2 Diagnostic Device and Nanoprobes
6.2.1 Biosensors
6.2.2 Microarrays
6.3 Quantum Dots for Early Cancer Detection
6.3.1 Detection of primary Cancers
6.3.2 Quantum Dots for Tumor Imaging

Cancer Therapeutics with Nanomedicines
7.1 Nanomedicine as Therapeutic Agents
7.1.1 Photodynamic Therapy
7.1.2 Photo Thermal Therapy
7.2 Nanomedicines as Prophylactic and Therapeutic Approach
7.2.1 Cancer Cell Destruction
7.3 Nanomedicine in Breast Cancer
7.4 Nanomedicine in Pancreatic Cancer
7.5 Nanomedicine in Brain Cancer
7.6 Nanomedicine in Lung Cancer

Cancer Imaging with Nanomedicine
8.1 Positron Emission Tomography
8.1.1 Applications in various Cancers
8.2 Single Photon Emitted Tomography
8.2.1 Computed Tomography
8.3 Magnetic Resonance Imaging (MRI)
8.3.1 Optical Imaging

Drug Delivery with Nanomedicines
9.1 Nanocarrier and Chemotherapy
9.1.1 Peptide Nanomedicine- An Example of Nanocarrier Chemotherapy
9.2 Nanomedicine Endocytosis and Intracellular Mechanisms
9.3 Factors Affecting Drug Delivery

Global Cancer Nanomedicine Market Overview
10.1 Current Market Scenario
10.2 Global Cancer Nanomedicine Clinical Pipeline Overview

Global Nanomedicine Market Dynamics
11.1 Encouraging Market Aspects
11.2 Commercialization Challenges

Global Cancer Nanomedicine Future Prospect

Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
13.1 Research
13.2 Preclinical
13.3 Phase-I
13.4 Phase-I/II
13.5 Phase-II
13.6 Phase-III

Marketed Cancer Nanomedicine Clinical Insight by Company, Indication and Phase
14.1 Caelyx and Doxil
14.2 Albumin-Bound Paclitaxel (Abraxane and Coraxane)
14.3 Nilotinib (Tasigna)
14.4 Paclitaxel Polymeric Micelle Formulation (Cynviloq and Genexol-PM)
14.5 Paclitaxel Liposomal
14.6 Vincristine Liposomal (Marqibo)
14.7 Rexin-G
14.8 Paclitaxel Nanoparticle (Nanoxel)

Competitive Landscape
15.1 Abraxis BioScience
15.2 Access Pharmaceuticals
15.3 Alnylam Pharmaceuticals
15.4 Amgen
15.5 Arrowhead Research
15.6 BIND Therapeutics
15.7 Cadila Healthcare
15.8 Celegen Corporation
15.9 Celsion Corporation
15.10 Genzyme Corporation
15.11 Merck
15.12 NanoCarrier
15.13 Nippon Kayaku
15.14 Nanobiotix
15.15 Novavax
15.16 Pfizer
15.17 Roche
15.18 Samyang
15.19 Sanofi
15.20 Takeda Pharmaceutical

Figure 1-1: Goals of Nanomedicines
Figure 2-1: Advantages of Nanomedicines over Conventional Therapies
Figure 3-1: Various Classes of Nanomedicines
Figure 3-2: Classification of Nanoparticles
Figure 3-3: Classification on Basis of Applicability
Figure 3-4: Dimensional Nanoconstructs
Figure 4-1: Mechanism of Nanomedicine to Destruct Tumor Cells
Figure 4-2: Vasculature of Tumor and Normal Cell
Figure 4-3: Nanoparticle Drug Delivery Benchmark
Figure 4-4: Liposomes as Nanocarriers
Figure 4-5: Structure of Dendrimers
Figure 4-6: Diverse Drug Release Mechanisms
Figure 5-1: Structure of Nanospheres and Nanocapsules
Figure 5-2: Processes Involved in Organic Polymeric Nanoparticles
Figure 5-3: Nanoparticle Production Methods
Figure 5-4: Different Categories of Emulsions
Figure 5-5: Scheme of Different Strategies of Interfacial Polymerization
Figure 5-6: Different Type of Inorganic Nanoparticle
Figure 5-7: Synthesis of Gold Nanoparticles
Figure 6-1: Functioning of Biosensors in Cancer Detection
Figure 6-2: Detection of Cancer Cells with Quantum Dots
Figure 7-1: Cancer Therapeutics with Nanomedicines
Figure 7-2: Cancer Cell Destruction via Nanomedicines
Figure 7-3: Drug Delivery across Blood Brain Barrier
Figure 8-1: Cancer Imaging Via Various Techniques
Figure 9-1: Nanomedicine and Cell Intake Mechanisms
Figure 9-2: Factors Affecting Drug Delivery
Figure 10-1: Global Nanomedicine Market (US$ Billion), 2013-2022
Figure 10-2: Global - Cancer Nanoparticle Pipeline by Phase (%), 2016 till 2022
Figure 10-3: Global - Cancer Nanoparticle Pipeline by Phase (Numbers), 2016 till 2022
Figure 10-4: Global - Cancer Nanoparticle Pipeline by Phase (%),2016 till 2022
Figure 10-5: Global - Cancer Nanoparticle Pipeline by Phase (Numbers), 2016 till 2022
Figure 11-1: Driving Parameters of Nanomedicines
Figure 11-2: Challenges of Nanomedicine Market
Figure 15-1: Arrowhead Research Corporation Clinical Pipeline
Figure 15-2: NanoCarrier Clinical Pipeline

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.